Suppression of antibodies to nucleic acids with polyinosinic-polycytidylic acid and cyclophosphamide in murine lupus.
D000818:Animals; D000906:Antibodies; D001327:Autoimmune Diseases / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004247:DNA; D005260:Female; D007108:Immune Tolerance; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D008297:Male; D051379:Mice; D009696:Nucleic Acids; D009705:Nucleosides; D012313:RNA / Q000627:therapeutic use*; D012376:Rodent Diseases / Q000188:drug therapy
D000906:Antibodies; D009696:Nucleic Acids; D009705:Nucleosides; D012313:RNA; D003520:Cyclophosphamide; D004247:DNA